ITX Stock Overview
Itaconix plc, together with its subsidiaries, designs, develops, manufactures, and sells bio-based polymers for personal care, home care, and industrial sectors in North America and Europe.
Price History & Performance
|Historical stock prices|
|Current Share Price||UK£0.053|
|52 Week High||UK£0.11|
|52 Week Low||UK£0.028|
|1 Month Change||-10.92%|
|3 Month Change||27.71%|
|1 Year Change||-3.64%|
|3 Year Change||186.49%|
|5 Year Change||-75.63%|
|Change since IPO||-94.88%|
Recent News & Updates
|ITX||GB Chemicals||GB Market|
Return vs Industry: ITX exceeded the UK Chemicals industry which returned -26.4% over the past year.
Return vs Market: ITX exceeded the UK Market which returned -8.2% over the past year.
|ITX Average Weekly Movement||11.9%|
|Chemicals Industry Average Movement||7.2%|
|Market Average Movement||5.4%|
|10% most volatile stocks in GB Market||10.8%|
|10% least volatile stocks in GB Market||2.7%|
Stable Share Price: ITX is more volatile than 90% of UK stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: ITX's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
Itaconix plc, together with its subsidiaries, designs, develops, manufactures, and sells bio-based polymers for personal care, home care, and industrial sectors in North America and Europe. The company’s home care and industrial products include Itaconix TSI, Itaconix DSP, Itaconix CHT, and Itaconix VELASOFT water soluble polymers; and Itaconix ZINADOR 22L and 35L, which are water soluble odor neutralizers. Its personal care products comprise Itaconix VELAFRESH ZP20 and ZP30 that are water soluble fixating complexes; and Nouryon Amaze SP, a hair styling ingredient.
Itaconix Fundamentals Summary
|ITX fundamental statistics|
Is ITX overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ITX income statement (TTM)|
|Cost of Revenue||US$1.90m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.001|
|Net Profit Margin||-17.53%|
How did ITX perform over the long term?See historical performance and comparison
Is ITX undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 1/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ITX?
Other financial metrics that can be useful for relative valuation.
|What is ITX's n/a Ratio?|
Price to Sales Ratio vs Peers
How does ITX's PS Ratio compare to its peers?
|ITX PS Ratio vs Peers|
|Company||PS||Estimated Growth||Market Cap|
BIOM Biome Technologies
HMI Harvest Minerals
GPL Graft Polymer (UK)
Price-To-Sales vs Peers: ITX is good value based on its Price-To-Sales Ratio (11.1x) compared to the peer average (13.4x).
Price to Earnings Ratio vs Industry
How does ITX's PE Ratio compare vs other companies in the GB Chemicals Industry?
Price-To-Sales vs Industry: ITX is expensive based on its Price-To-Sales Ratio (11.1x) compared to the UK Chemicals industry average (3.1x)
Price to Sales Ratio vs Fair Ratio
What is ITX's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||11.1x|
|Fair PS Ratio||3.6x|
Price-To-Sales vs Fair Ratio: ITX is expensive based on its Price-To-Sales Ratio (11.1x) compared to the estimated Fair Price-To-Sales Ratio (3.6x).
Share Price vs Fair Value
What is the Fair Price of ITX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate ITX's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate ITX's fair value for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is Itaconix forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Future Growth Score5/6
Future Growth Score 5/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ITX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.9%).
Earnings vs Market: ITX is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ITX is expected to become profitable in the next 3 years.
Revenue vs Market: ITX's revenue (42.5% per year) is forecast to grow faster than the UK market (4.6% per year).
High Growth Revenue: ITX's revenue (42.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ITX's Return on Equity is forecast to be high in 3 years time
Discover growth companies
How has Itaconix performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ITX is currently unprofitable.
Growing Profit Margin: ITX is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: ITX is unprofitable, but has reduced losses over the past 5 years at a rate of 44% per year.
Accelerating Growth: Unable to compare ITX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ITX is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-17.8%).
Return on Equity
High ROE: ITX has a negative Return on Equity (-70.11%), as it is currently unprofitable.
Discover strong past performing companies
How is Itaconix's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: ITX's short term assets ($2.3M) exceed its short term liabilities ($1.2M).
Long Term Liabilities: ITX's short term assets ($2.3M) exceed its long term liabilities ($1.5M).
Debt to Equity History and Analysis
Debt Level: ITX is debt free.
Reducing Debt: ITX had no debt 5 years ago.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ITX has sufficient cash runway for 4 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: ITX has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 22% each year
Discover healthy companies
What is Itaconix current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ITX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ITX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ITX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ITX's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as ITX has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
John Shaw (62 yo)
Mr. John Roger Shaw has been Chief Executive Officer of Itaconix PLC since July 12, 2018 and serves as its Director since November 2018. He served as President of Itaconix US of Itaconix PLC until July 12,...
CEO Compensation Analysis
Compensation vs Market: Insufficient data to establish whether John's total compensation is reasonable compared to companies of similar size in the UK market.
Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.
Experienced Management: ITX's management team is considered experienced (2.9 years average tenure).
Experienced Board: ITX's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Itaconix plc's employee growth, exchange listings and data sources
- Name: Itaconix plc
- Ticker: ITX
- Exchange: AIM
- Founded: 2012
- Industry: Commodity Chemicals
- Sector: Materials
- Implied Market Cap: UK£23.857m
- Shares outstanding: 450.13m
- Website: https://www.itaconix.com
Number of Employees
- Itaconix plc
- 2 Marin Way
- Unit 1
- New Hampshire
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/17 00:00|
|End of Day Share Price||2022/08/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.